CLNN – clene inc. (US:NASDAQ)
Stock Stats
News
Clene to Present at the Emerging Growth Conference
Clene Announces Additional CNM-Au8 Biomarker Data Supporting Potential NDA Filing for Upcoming In-Person FDA Meeting
Clene announces registered direct offering of over $28M [Seeking Alpha]
Clene (NASDAQ:CLNN) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $23.00 price target on the stock.
Clene Announces Registered Direct Offering of Over $28 Million
Form 4 Clene Inc. For: Feb 03 Filed by: Ugwumba Chidozie
Form 144 Clene Inc. Filed by: SymBiosis Capital Partners, LLC
Form 4 Clene Inc. For: Jan 29 Filed by: Ugwumba Chidozie
Form 4 Clene Inc. For: Jan 26 Filed by: Ugwumba Chidozie
Form 4 Clene Inc. For: Jan 22 Filed by: Ugwumba Chidozie
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.